Galectins in Protozoan Parasitic Diseases: Potential Applications in Diagnostics and Therapeutics.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI

Parasites* ; Parasitic Diseases*/diagnosis ; Parasitic Diseases*/drug therapy ; Leishmaniasis*/diagnosis ; Leishmaniasis*/drug therapy ; Chagas Disease*/diagnosis ; Chagas Disease*/drug therapy ; Malaria*; Animals ; Galectins

Neglected tropical diseases (NTDs) constitute a group of diseases that generally develop in tropical or subtropical climatic conditions and are related to poverty. Within the spectrum of NTDs, diseases caused by protozoa such as malaria, Chagas disease, and leishmaniasis exhibit elevated mortality rates, thereby constituting a substantial public health concern. Beyond their protozoan etiology, these NTDs share other similarities, such as the challenge of control and the lack of affordable, safe, and effective drugs. In view of the above, the need to explore novel diagnostic predictors and therapeutic targets for the treatment of these parasitic diseases is evident. In this context, galectins are attractive because they are a set of lectins bound to β-galactosides that play key roles in a variety of cellular processes, including host-parasite interaction such as adhesion and entry of parasites into the host cells, and participate in antiparasitic immunity in either a stimulatory or inhibitory manner, especially the galectins-1, -2, -3, and -9. These functions bestow upon galectins significant therapeutic prospects in the context of managing and diagnosing NTDs. Thus, the present review aims to elucidate the potential role of galectins in the diagnosis and treatment of malaria, leishmaniasis, and Chagas disease.

Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165689. (PMID: 32001300)
Parasit Vectors. 2019 Nov 11;12(1):534. (PMID: 31711531)
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129755. (PMID: 33011338)
J Immunol. 2004 Aug 1;173(3):1902-7. (PMID: 15265923)
Annu Rev Pathol. 2020 Jan 24;15:315-343. (PMID: 31648610)
Int J Mol Sci. 2020 Dec 03;21(23):. (PMID: 33287402)
Biomolecules. 2021 Mar 15;11(3):. (PMID: 33804076)
Lancet. 2018 Jan 6;391(10115):82-94. (PMID: 28673423)
Immunobiology. 2010 Jun;215(6):475-85. (PMID: 19720428)
Arq Bras Cardiol. 1999 Mar;72(3):247-80. (PMID: 10513039)
Cardiology. 2017;136(1):33-39. (PMID: 27548475)
J Am Coll Cardiol. 2013 Aug 27;62(9):767-76. (PMID: 23770163)
Malar J. 2018 Oct 19;17(1):371. (PMID: 30340592)
Malar J. 2016 Aug 11;15(1):403. (PMID: 27515948)
Eur J Immunol. 2013 Jul;43(7):1806-17. (PMID: 23592449)
Microsc Res Tech. 2018 Sep;81(9):1042-1058. (PMID: 30207623)
Clin Lab Med. 2010 Mar;30(1):93-129. (PMID: 20513543)
Immunol Rev. 2009 Jul;230(1):172-87. (PMID: 19594636)
Health Promot Perspect. 2021 Dec 19;11(4):430-433. (PMID: 35079586)
Protein Cell. 2016 Mar;7(3):159-74. (PMID: 26936847)
J Immunol. 2015 Oct 1;195(7):3311-24. (PMID: 26324777)
Nat Rev Immunol. 2013 Jun;13(6):427-37. (PMID: 23665520)
Br J Clin Pharmacol. 2022 Feb;88(2):383-402. (PMID: 33314266)
Front Microbiol. 2023 Feb 02;13:1052478. (PMID: 36817103)
Curr Drug Targets. 2023;24(2):201-210. (PMID: 36503390)
Sci Rep. 2017 Jul 21;7(1):6171. (PMID: 28733584)
Methods Mol Biol. 2015;1207:371-95. (PMID: 25253154)
Biomolecules. 2021 Dec 20;11(12):. (PMID: 34944551)
J Proteomics. 2015 Sep 8;127(Pt A):103-13. (PMID: 25982387)
Biochim Biophys Acta Gen Subj. 2021 Dec;1865(12):129992. (PMID: 34508835)
Int J Biochem Cell Biol. 2021 Jan;130:105881. (PMID: 33181315)
PLoS Negl Trop Dis. 2015 Oct 09;9(10):e0004148. (PMID: 26451839)
Mol Immunol. 2016 Aug;76:22-34. (PMID: 27344022)
Infect Immun. 2012 Jul;80(7):2473-84. (PMID: 22585960)
Biomolecules. 2020 Mar 03;10(3):. (PMID: 32138174)
Parasitol Res. 2016 Feb;115(2):663-72. (PMID: 26486943)
J Infect. 2014 Nov;69 Suppl 1:S10-8. (PMID: 25238669)
Lancet. 2014 Feb 22;383(9918):723-35. (PMID: 23953767)
J Immunol. 2013 Jan 15;190(2):630-40. (PMID: 23241887)
Acta Diabetol. 2019 Apr;56(4):457-472. (PMID: 30603868)
Trends Parasitol. 2022 Feb;38(2):136-146. (PMID: 34561157)
Indian J Pediatr. 2017 Jul;84(7):521-528. (PMID: 28357581)
Histochem Cell Biol. 2020 Aug;154(2):135-153. (PMID: 32335744)
Future Microbiol. 2022 Jan;17:41-57. (PMID: 34877877)
Parasite Immunol. 2012 Jul;34(7):383-7. (PMID: 22486577)
PLoS One. 2009 Aug 27;4(8):e6793. (PMID: 19710907)
Nat Immunol. 2009 Sep;10(9):981-91. (PMID: 19668220)
Clin Immunol. 2008 Apr;127(1):78-88. (PMID: 18282810)
Adv Parasitol. 2017;97:1-45. (PMID: 28325368)
Histol Histopathol. 2014 Sep;29(9):1093-105. (PMID: 24696431)
Mediators Inflamm. 2018 Nov 5;2018:8696543. (PMID: 30524200)
Acta Trop. 2018 Jan;177:97-104. (PMID: 28986248)
J Infect Dis. 2015 Oct 1;212(7):1160-71. (PMID: 25805753)
Int J Mol Sci. 2018 Jan 26;19(2):. (PMID: 29373564)
Immunobiology. 2012 Jan;217(1):83-90. (PMID: 21899917)
Semin Diagn Pathol. 2019 May;36(3):164-169. (PMID: 31006555)
PLoS Pathog. 2016 Jan 14;12(1):e1005398. (PMID: 26765224)
Int J Mol Sci. 2022 Dec 23;24(1):. (PMID: 36613681)
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9731-6. (PMID: 19497882)
Parasitology. 2018 Apr;145(4):497-507. (PMID: 27974063)
Glycobiology. 2015 Jul;25(7):792-803. (PMID: 25804418)
Front Cell Infect Microbiol. 2020 Jul 02;10:285. (PMID: 32714876)
J Leukoc Biol. 2001 Jul;70(1):73-9. (PMID: 11435488)
Stem Cells Int. 2017;2017:3282656. (PMID: 28769980)
J Biol Chem. 2003 Jun 20;278(25):22223-30. (PMID: 12684513)
Front Microbiol. 2021 Jul 16;12:712538. (PMID: 34335547)
Pathol Res Pract. 2017 Sep;213(9):1207-1214. (PMID: 28554765)
Adv Exp Med Biol. 2020;1204:169-196. (PMID: 32152947)
Cell Immunol. 2021 Mar;361:104287. (PMID: 33494007)
Front Immunol. 2021 Nov 24;12:758052. (PMID: 34899708)
Am J Pathol. 2017 May;187(5):1134-1146. (PMID: 28322201)
Nat Commun. 2022 Mar 3;13(1):1157. (PMID: 35241678)
Allergol Int. 2017 Jul;66(3):432-439. (PMID: 27876361)
Am J Dermatopathol. 2019 Dec;41(12):897-907. (PMID: 30998516)
J Biosci. 2016 Sep;41(3):507-34. (PMID: 27581941)
Cell Mol Immunol. 2021 Oct;18(10):2443-2454. (PMID: 33203936)
Expert Opin Ther Targets. 2023 Jul-Dec;27(10):911-925. (PMID: 37772733)
Sci Rep. 2016 Aug 24;6:32024. (PMID: 27554340)
Clin Exp Immunol. 2001 May;124(2):266-73. (PMID: 11422204)
Glycobiology. 2015 Feb;25(2):197-210. (PMID: 25267603)
Curr Med Chem. 2019;26(23):4380-4402. (PMID: 28875841)
Biochim Biophys Acta. 2015 Apr;1855(2):235-47. (PMID: 25819524)
Drug Des Devel Ther. 2017 Dec 22;12:25-40. (PMID: 29317800)
Mediators Inflamm. 2017;2017:9247574. (PMID: 28607536)
J Cell Sci. 2015 Jul 1;128(13):2213-9. (PMID: 26092931)
J Biol Chem. 2018 Dec 28;293(52):20249-20262. (PMID: 30385505)
J Biol Chem. 2002 May 17;277(20):17663-70. (PMID: 11882664)
J Cell Sci. 2018 May 1;131(9):. (PMID: 29717004)
Parasitol Res. 2016 Feb;115(2):587-95. (PMID: 26494364)
Acta Trop. 2023 Feb;238:106792. (PMID: 36509129)
Glycobiology. 2021 Nov 18;31(10):1378-1389. (PMID: 34192330)
Mol Aspects Med. 2017 Oct;57:1-29. (PMID: 28159546)
Neuromolecular Med. 2021 Jun;23(2):267-284. (PMID: 32865657)
Arq Bras Cardiol. 2021 Feb;116(2):248-256. (PMID: 33656072)
J Infect Dis. 2010 Jul 1;202(1):117-24. (PMID: 20500087)
Infect Dis Poverty. 2018 Jun 18;7(1):67. (PMID: 29950174)
Future Microbiol. 2011 Dec;6(12):1485-500. (PMID: 22122444)
Stem Cell Res Ther. 2020 Nov 5;11(1):471. (PMID: 33153471)
Trends Parasitol. 2022 Apr;38(4):316-334. (PMID: 34896016)

0002/2014 Fundação de Amparo à Pesquisa do Estado da Bahia

Keywords: Chagas disease; galectins; leishmaniasis; malaria

0 (Galectins)

Date Created: 20231209 Date Completed: 20231216 Latest Revision: 20240131

20240201

PMC10705098

10.3390/cells12232671

38067100